Ebola vaccine–induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effects.

MLA

Meyer, Michelle, et al. “Ebola Vaccine–induced Protection in Nonhuman Primates Correlates with Antibody Specificity and Fc-Mediated Effects.” Science Translational Medicine, vol. 13, no. 602, July 2021, pp. 1–19. EBSCOhost, https://doi.org/10.1126/scitranslmed.abg6128.

APA

Meyer, M., Gunn, B. M., Malherbe, D. C., Gangavarapu, K., Yoshida, A., Pietzsch, C., Kuzmina, N. A., Saphire, E. O., Collins, P. L., Crowe, J. E., Zhu, J. J., Suchard, M. A., Brining, D. L., Mire, C. E., Cross, R. W., Geisbert, J. B., Samal, S. K., Andersen, K. G., Alter, G., & Geisbert, T. W. (2021). Ebola vaccine–induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effects. Science Translational Medicine, 13(602), 1–19. https://doi.org/10.1126/scitranslmed.abg6128

Chicago

Meyer, Michelle, Bronwyn M. Gunn, Delphine C. Malherbe, Karthik Gangavarapu, Asuka Yoshida, Colette Pietzsch, Natalia A. Kuzmina, et al. 2021. “Ebola Vaccine–induced Protection in Nonhuman Primates Correlates with Antibody Specificity and Fc-Mediated Effects.” Science Translational Medicine 13 (602): 1–19. doi:10.1126/scitranslmed.abg6128.